Cancer Gene Therapy - Table of Contents alert Volume 24 Issue 3

If you are unable to see the message below, click here to view.

Advertisement A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research. Open for submissions >>  TABLE OF CONTENTS Volume 24, Issue 3 (March 2017) In this issue Editorial Reviews Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective Richard P Junghans Cancer Gene Ther 2017 24: 89-99; 10.1038/cgt.2016.82 Full Text Reviews Top Myeloid-derived suppressor cells and their role in pancreatic cancer M Pergamo and G Miller Cancer Gene Ther 2017 24: 100-105; advance online publication, December 2, 2016; 10.1038/cgt.2016.65 Abstract | Full Text T-cell programming in pancreatic adenocarcinoma: a review Y D Seo and V G Pillarisetty Cancer Gene Ther 2017 24: 106-113; advance online publication, December 2, 2016; 10.1038/cgt.2016.66 Abstract | Full Text Immunosuppression in liver tumors: opening the portal to effective immunotherapy P Guha, J Reha and S C Katz Cancer Gene Ther 2017 24: 114-120; advance online publication, December 2, 2016; 10.1038/cgt.2016.54 Abstract | Full Text Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them S Sengupta, G Mao, Z S Gokaslan and P Sampath Cancer Gene Ther 2017 24: 121-129; advance online publication, October 21, 2016; 10.1038/cgt.2016.46 Abstract | Full Text Current status of immunotherapy for gastrointestinal stromal tumor Y Tan, J C Trent, B A Wilky, D A Kerr and A E Rosenberg Cancer Gene Ther 2017 24: 130-133; advance online publication, February 10, 2017; 10.1038/cgt.2016.58 Abstract | Full Text Gene-expression profiling to predict responsiveness to immunotherapy N B Jamieson and A V Maker Cancer Gene Ther 2017 24: 134-140; advance online publication, November 11, 2016; 10.1038/cgt.2016.63 Abstract | Full Text Combinatorial immunotherapy for melanoma D D George, V A Armenio and S C Katz Cancer Gene Ther 2017 24: 141-147; advance online publication, November 11, 2016; 10.1038/cgt.2016.56 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.